glp 1 drugs insurance coverage MCT2D Medicaid Coverage of and Spending
Description
[DOI] [PubMed] [Google Scholar] 40.Pocai A
This medications safety profile has not been studied in patients under the age of 18, pregnant and lactating people, or those with normal BMIs. At the time of publishing, the FDA has only approved three GLP-1 agonists for weight loss: Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)
Theres also been a spike in adverse reactions to compounded GLP-1s that the FDA suspects is due to accidental overdosing
Bailey, J
(Abstract 57-OR) [Google Scholar] 48.Pratley RE, Nauck MA, Bailey T, et al
